Pomanda estimates the enterprise value of BIOCATALYSTS LIMITED at £16.5m based on a Turnover of £20.6m and 0.8x industry multiple (adjusted for size and gross margin).
biocatalysts limitedEstimated Valuation
£23.6m
Pomanda estimates the enterprise value of BIOCATALYSTS LIMITED at £23.6m based on an EBITDA of £4.2m and a 5.64x industry multiple (adjusted for size and gross margin).
biocatalysts limitedEstimated Valuation
£18.8m
Pomanda estimates the enterprise value of BIOCATALYSTS LIMITED at £18.8m based on Net Assets of £11.3m and 1.66x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biocatalysts LimitedOverview
Biocatalysts Limited is a live company located in cardiff, CF15 7QQ with a Companies House number of 02570883. It operates in the manufacture of other inorganic basic chemicals sector, SIC Code 20130. Founded in December 1990, it's largest shareholder is
b.r.a.i.n. biotechnology research & information network uk 2 ltd
with a 100% stake. Biocatalysts Limited is a mature,
large sized company, Pomanda has estimated its turnover at
£20.6m with
high
growth in recent years.
Pomanda's financial health check has awarded Biocatalysts Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating4.5out of 5
5 Strong
2 Regular
5 Weak
Size
annual sales of £20.6m, make it smaller than the average company (£35.4m)
£20.6m - Biocatalysts Limited
£35.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 15%, show it is growing at a faster rate (9%)
15% - Biocatalysts Limited
9% - Industry AVG
Production
with a gross margin of 38.2%, this company has a lower cost of product (22%)
38.2% - Biocatalysts Limited
22% - Industry AVG
Profitability
an operating margin of 16.1% make it more profitable than the average company (6.4%)
16.1% - Biocatalysts Limited
6.4% - Industry AVG
Employees
with 101 employees, this is similar to the industry average (89)
101 - Biocatalysts Limited
89 - Industry AVG
Pay Structure
on an average salary of £53.5k, the company has an equivalent pay structure (£62.7k)
£53.5k - Biocatalysts Limited
£62.7k - Industry AVG
Efficiency
resulting in sales per employee of £204k, this is less efficient (£413.8k)
£204k - Biocatalysts Limited
£413.8k - Industry AVG
Debtor Days
it gets paid by customers after 108 days, this is later than average (48 days)
108 days - Biocatalysts Limited
48 days - Industry AVG
Creditor Days
its suppliers are paid after 110 days, this is slower than average (37 days)
110 days - Biocatalysts Limited
37 days - Industry AVG
Stock Days
it holds stock equivalent to 171 days, this is more than average (52 days)
171 days - Biocatalysts Limited
52 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 14 weeks, this is more cash available to meet short term requirements (9 weeks)
14 weeks - Biocatalysts Limited
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 66.3%, this is a higher level of debt than the average (47.7%)
66.3% - Biocatalysts Limited
47.7% - Industry AVG
BIOCATALYSTS LIMITED financials
EXPORT
Biocatalysts Limited's latest turnover from September 2023 is £20.6 million and the company has net assets of £11.3 million. According to their latest financial statements, Biocatalysts Limited has 101 employees and maintains cash reserves of £2.5 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Turnover
20,605,182
18,871,300
15,568,663
13,450,566
12,075,872
10,957,664
9,546,107
7,977,697
7,605,775
8,384,918
7,487,349
6,843,346
8,751,579
9,803,852
Other Income Or Grants
Cost Of Sales
12,730,943
11,445,823
9,151,083
7,818,045
6,630,189
5,948,723
5,483,866
4,963,945
4,607,418
5,081,638
4,724,753
4,347,503
6,565,306
7,182,207
Gross Profit
7,874,239
7,425,477
6,417,580
5,632,521
5,445,683
5,008,941
4,062,241
3,013,752
2,998,357
3,303,280
2,762,596
2,495,843
2,186,274
2,621,645
Admin Expenses
4,550,893
4,940,197
4,682,755
3,553,888
4,644,061
3,490,241
3,021,928
2,275,899
2,404,724
2,542,610
2,138,563
2,087,583
1,908,698
2,083,450
-1,904,076
Operating Profit
3,323,346
2,485,280
1,734,825
2,078,633
801,622
1,518,700
1,040,313
737,853
593,633
760,670
624,033
408,260
277,576
538,195
1,904,076
Interest Payable
289,421
67,245
63,387
97,381
47,669
41,957
27,300
53
16,960
25,537
31,002
20,441
2,190
2,190
Interest Receivable
5,323
1,875
133
5,557
2,847
2,539
1,500
1,216
1,898
995
Pre-Tax Profit
3,033,925
2,418,035
1,671,438
1,981,252
753,953
1,482,066
1,014,888
737,933
582,230
737,980
595,570
389,319
278,792
537,903
1,902,881
Tax
-790,154
-380,920
-413,907
320,340
-14,101
-289,615
-229,691
-4,580
-12,657
83,869
-8,739
30,603
-72,486
-150,613
-532,807
Profit After Tax
2,243,771
2,037,115
1,257,531
2,301,592
739,852
1,192,451
785,197
733,353
569,573
821,849
586,831
419,922
206,306
387,290
1,370,074
Dividends Paid
149,676
238,797
229,940
208,477
187,595
176,404
Retained Profit
2,243,771
2,037,115
1,257,531
2,301,592
739,852
1,042,775
546,400
503,413
569,573
613,372
399,236
243,518
206,306
387,290
1,370,074
Employee Costs
5,408,407
4,575,167
3,914,559
3,386,078
3,224,413
2,747,590
2,427,179
2,078,280
1,946,267
1,728,130
1,469,440
1,609,716
1,017,692
1,094,740
Number Of Employees
101
88
78
72
67
61
56
55
58
49
44
43
21
23
EBITDA*
4,191,275
3,288,544
2,369,650
2,432,380
1,155,833
1,857,616
1,370,218
1,073,795
918,900
1,092,485
887,479
663,927
514,069
719,092
2,056,979
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Tangible Assets
14,078,990
12,791,858
9,815,360
10,026,221
9,012,233
4,131,962
3,169,711
3,107,163
3,262,335
3,532,885
3,741,894
2,877,688
2,993,623
3,091,831
2,867,299
Intangible Assets
4,915,022
2,007
2,007
2,007
2,007
2,007
2,007
2,007
2,007
2,007
2,007
2,007
2,007
2,007
2,007
Investments & Other
1,260,255
1,261,215
3
2
2
Debtors (Due After 1 year)
Total Fixed Assets
20,254,267
14,055,080
9,817,367
10,028,228
9,014,240
4,133,969
3,171,718
3,109,170
3,264,342
3,534,892
3,743,901
2,879,695
2,995,633
3,093,840
2,869,308
Stock & work in progress
5,967,926
2,336,292
1,338,898
1,116,058
917,134
746,071
761,272
871,072
764,613
1,147,302
1,048,786
911,091
783,215
568,072
443,403
Trade Debtors
6,143,444
3,300,130
2,798,751
1,964,533
1,896,631
1,556,131
1,494,250
1,142,467
1,010,450
976,753
1,005,174
1,051,457
1,388,776
1,640,006
892,639
Group Debtors
Misc Debtors
545,221
478,171
158,703
302,804
638,485
195,899
653,005
370,017
232,235
274,787
244,005
163,095
Cash
2,472,802
1,304,454
3,027,825
951,265
714,509
3,182,205
2,689,612
976,682
795,047
775,948
275,430
536,049
125,348
361,061
398,003
misc current assets
total current assets
15,129,393
7,419,047
7,324,177
4,334,660
4,166,759
5,680,306
5,598,139
3,360,238
2,802,345
3,174,790
2,573,395
2,661,692
2,297,339
2,569,139
1,734,045
total assets
35,383,660
21,474,127
17,141,544
14,362,888
13,180,999
9,814,275
8,769,857
6,469,408
6,066,687
6,709,682
6,317,296
5,541,387
5,292,972
5,662,979
4,603,353
Bank overdraft
1,278,190
120,497
118,091
86,968
25,586
433,228
410,398
276,955
Bank loan
73,005
112,853
Trade Creditors
3,848,779
2,358,247
1,071,243
389,231
1,430,190
554,025
736,509
398,614
361,836
622,050
436,155
397,760
1,068,161
1,388,034
697,136
Group/Directors Accounts
208,740
other short term finances
102,239
440,525
hp & lease commitments
338,708
176,699
211,984
224,617
111,344
5,027
4,643
15,511
87,320
82,995
75,440
23,423
other current liabilities
2,962,900
3,245,926
2,125,783
1,308,397
1,506,348
900,508
590,454
361,711
369,373
327,201
474,391
179,005
total current liabilities
8,637,317
5,901,369
3,527,101
2,111,452
3,513,993
1,532,565
1,444,459
775,836
818,529
1,465,474
1,396,384
877,143
1,068,161
1,388,034
697,136
loans
10,833,741
1,440,076
1,560,573
1,678,664
1,740,046
1,147,468
1,178,695
478,592
697,138
67,384
hp & lease commitments
1,694,536
44,723
221,422
433,406
238,280
8,821
14,857
14,957
102,626
183,619
85,345
Accruals and Deferred Income
348,909
374,909
400,909
426,913
other liabilities
235,674
688,779
637,384
1,116,120
1,336,923
1,267,075
provisions
1,715,866
998,306
753,910
292,355
89,261
181,600
196,620
237,294
242,611
257,834
94,885
119,636
145,021
180,658
201,684
total long term liabilities
14,828,726
2,858,014
2,936,814
2,831,338
2,067,587
1,337,889
1,390,172
237,294
946,347
360,460
1,394,480
902,119
1,261,141
1,517,581
1,536,143
total liabilities
23,466,043
8,759,383
6,463,915
4,942,790
5,581,580
2,870,454
2,834,631
1,013,130
1,764,876
1,825,934
2,790,864
1,779,262
2,329,302
2,905,615
2,233,279
net assets
11,323,253
12,714,744
10,677,629
9,420,098
7,599,419
6,943,821
5,935,226
5,456,278
4,301,811
4,883,748
3,526,432
3,762,125
2,963,670
2,757,364
2,370,074
total shareholders funds
11,323,253
12,714,744
10,677,629
9,420,098
7,599,419
6,943,821
5,935,226
5,456,278
4,301,811
4,883,748
3,526,432
3,762,125
2,963,670
2,757,364
2,370,074
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Operating Activities
Operating Profit
3,323,346
2,485,280
1,734,825
2,078,633
801,622
1,518,700
1,040,313
737,853
593,633
760,670
624,033
408,260
277,576
538,195
1,904,076
Depreciation
867,929
803,264
634,825
353,747
354,211
338,916
329,905
335,942
325,267
331,815
263,446
255,667
236,493
180,897
152,903
Amortisation
Tax
-790,154
-380,920
-413,907
320,340
-14,101
-289,615
-229,691
-4,580
-12,657
83,869
-8,739
30,603
-72,486
-150,613
-532,807
Stock
3,631,634
997,394
222,840
198,924
171,063
-15,201
-109,800
106,459
-382,689
98,516
137,695
127,876
215,143
124,669
443,403
Debtors
2,910,364
820,847
690,117
-267,779
783,086
-395,225
634,771
269,799
-8,855
2,361
34,627
-174,224
-251,230
747,367
892,639
Creditors
1,490,532
1,287,004
682,012
-1,040,959
876,165
-182,484
337,895
36,778
-260,214
185,895
38,395
-670,401
-319,873
690,898
697,136
Accruals and Deferred Income
-309,026
1,094,143
791,382
228,962
605,840
310,054
228,743
-7,662
42,172
-147,190
295,386
179,005
Deferred Taxes & Provisions
717,560
244,396
461,555
203,094
-92,339
-15,020
-40,674
-5,317
-15,223
162,949
-24,751
-25,385
-35,637
-21,026
201,684
Cash flow from operations
-1,241,811
3,714,926
2,977,735
2,212,672
1,577,249
2,090,977
1,141,520
716,756
1,064,522
1,277,131
1,015,448
224,097
122,160
366,315
1,086,950
Investing Activities
capital expenditure
-1,301,167
-393,015
-180,770
-122,806
-1,127,652
-139,732
-138,285
-405,429
-3,022,209
Change in Investments
-960
1,261,215
-3
1
2
cash flow from investments
960
-1,261,215
-1,301,167
-393,015
-180,770
-122,806
-1,127,652
-139,729
-138,286
-405,429
-3,022,211
Financing Activities
Bank loans
-73,005
-39,848
112,853
Group/Directors Accounts
208,740
Other Short Term Loans
-102,239
-338,286
440,525
Long term loans
9,393,665
-120,497
-118,091
-61,382
592,578
-31,227
1,178,695
-478,592
-218,546
697,138
-67,384
67,384
Hire Purchase and Lease Commitments
1,811,822
-211,984
-224,617
308,399
335,776
-5,652
3,989
-86,766
-83,344
-73,438
150,291
108,768
other long term liabilities
235,674
-688,779
688,779
-637,384
637,384
-1,116,120
-220,803
69,848
1,267,075
share issue
-3,635,262
-480,913
-84,254
-34,180
-67,452
651,054
-1,151,510
743,944
-634,929
554,937
1,000,000
interest
-289,421
-67,245
-63,387
-97,381
-47,669
-36,634
-25,425
80
-11,403
-22,690
-28,463
-18,941
1,216
-292
-1,195
cash flow from financing
7,725,218
-399,726
-508,334
-669,563
1,163,951
-147,541
1,202,660
-124,411
-557,478
-468,160
-94,263
225,782
-219,587
2,172
2,333,264
cash and cash equivalents
cash
1,168,348
-1,723,371
2,076,560
236,756
-2,467,696
492,593
1,712,930
181,635
19,099
500,518
-260,619
410,701
-235,713
-36,942
398,003
overdraft
1,157,693
2,406
31,123
61,382
25,586
-433,228
22,830
133,443
276,955
change in cash
10,655
-1,725,777
2,045,437
175,374
-2,493,282
492,593
1,712,930
181,635
452,327
477,688
-394,062
133,746
-235,713
-36,942
398,003
biocatalysts limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for biocatalysts limited. Get real-time insights into biocatalysts limited's credit score, group structure and payment trends.
Perform a competitor analysis for biocatalysts limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in CF15 area or any other competitors across 12 key performance metrics.
The sole shareholder of Biocatalysts Limited is B.R.A.I.N. Biotechnology Research & Information Network Uk 2 Ltd.
b.r.a.i.n. biotechnology research & information network uk 2 ltd
100%
biocatalysts limited directors
Biocatalysts Limited currently has 2 directors.
The longest serving directors include
Mr Adriaan Moelker (Mar 2020) and
Mr Michael Schneiders (Apr 2023).
20130 - Manufacture of other inorganic basic chemicals
incorporation date
December 1990
age
35
incorporated
UK
ultimate parent company
B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND .
accounts
Group
last accounts submitted
September 2023
previous names
biocatalysts holdings limited (October 1995)
m.b.h.12 limited (January 1991)
accountant
-
auditor
MHA
address
cefn coed, parc nantgarw, cardiff, CF15 7QQ
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
biocatalysts limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to biocatalysts limited. Currently there are 4 open charges and 2 have been satisfied in the past.
biocatalysts limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOCATALYSTS LIMITED. This can take several minutes, an email will notify you when this has completed.
biocatalysts limitedCompanies House Filings - See Documents
